Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre-Jean Ferron

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
International Journal of Molecular Sciences|March 6, 2021
The Purinergic P2X7 Receptor-NLRP3 Inflammasome Pathway: A New Target in Alcoholic Liver Disease?Brendan Le Daré, Pierre-Jean Ferron, Thomas Gicquel
Toxins|July 2, 2021
Toxic Effects of Amanitins: Repurposing Toxicities toward New TherapeuticsBrendan Le Daré, Pierre-Jean Ferron, Thomas Gicquel
Medecine Sciences : M/S|March 19, 2021
[Once upon a time the hepatotoxicity…]Brendan Le Daré, Pierre-Jean Ferron, Thomas Gicquel
Marine Drugs|September 9, 2014
Comparative analysis of the cytotoxic effects of okadaic acid-group toxins on human intestinal cell linesPierre-Jean Ferron, Kevin Hogeveen, Valérie Fessard, et al.
Fundamental & Clinical Pharmacology|September 4, 2023
Busulfan induces steatosis in HepaRG cells but not in primary human hepatocytes: Possible explanations and implication for the prediction of drug-induced liver injuryJulien Allard, Simon Bucher, Pierre-Jean Ferron, et al.
Biochimie|September 6, 2020
Treatments in Covid-19 patients with pre-existing metabolic dysfunction-associated fatty liver disease: A potential threat for drug-induced liver injury?Pierre-Jean Ferron, Thomas Gicquel, Bruno Mégarbane, et al.
Current Protocols|January 19, 2026
Multi-Cellular Human Liver Organoids for Modeling Metabolic Dysfunction-Associated Steatotic Liver Disease and Drug-Induced Liver InjuryMaela Duclos, Zeineb Marzougui, Mariam Saleh, et al.
Toxins|February 25, 2016
Combined Effects of Lipophilic Phycotoxins (Okadaic Acid, Azapsiracid-1 and Yessotoxin) on Human Intestinal Cells ModelsPierre-Jean Ferron, Kevin Dumazeau, Jean-François Beaulieu, et al.
Toxicology Letters|April 19, 2021
In vivo and in vitro α-amanitin metabolism studies using molecular networkingBrendan Le Daré, Pierre-Jean Ferron, Aurélien Couette, et al.
Scientific Reports|November 17, 2020
New insights into quetiapine metabolism using molecular networkingBrendan Le Daré, Pierre-Jean Ferron, Pierre-Marie Allard, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
International Journal of Molecular Sciences|March 6, 2021
The Purinergic P2X7 Receptor-NLRP3 Inflammasome Pathway: A New Target in Alcoholic Liver Disease?Brendan Le Daré, Pierre-Jean Ferron, Thomas Gicquel
Toxins|July 2, 2021
Toxic Effects of Amanitins: Repurposing Toxicities toward New TherapeuticsBrendan Le Daré, Pierre-Jean Ferron, Thomas Gicquel
Medecine Sciences : M/S|March 19, 2021
[Once upon a time the hepatotoxicity…]Brendan Le Daré, Pierre-Jean Ferron, Thomas Gicquel
Marine Drugs|September 9, 2014
Comparative analysis of the cytotoxic effects of okadaic acid-group toxins on human intestinal cell linesPierre-Jean Ferron, Kevin Hogeveen, Valérie Fessard, et al.
Fundamental & Clinical Pharmacology|September 4, 2023
Busulfan induces steatosis in HepaRG cells but not in primary human hepatocytes: Possible explanations and implication for the prediction of drug-induced liver injuryJulien Allard, Simon Bucher, Pierre-Jean Ferron, et al.
Biochimie|September 6, 2020
Treatments in Covid-19 patients with pre-existing metabolic dysfunction-associated fatty liver disease: A potential threat for drug-induced liver injury?Pierre-Jean Ferron, Thomas Gicquel, Bruno Mégarbane, et al.
Current Protocols|January 19, 2026
Multi-Cellular Human Liver Organoids for Modeling Metabolic Dysfunction-Associated Steatotic Liver Disease and Drug-Induced Liver InjuryMaela Duclos, Zeineb Marzougui, Mariam Saleh, et al.
Toxins|February 25, 2016
Combined Effects of Lipophilic Phycotoxins (Okadaic Acid, Azapsiracid-1 and Yessotoxin) on Human Intestinal Cells ModelsPierre-Jean Ferron, Kevin Dumazeau, Jean-François Beaulieu, et al.
Toxicology Letters|April 19, 2021
In vivo and in vitro α-amanitin metabolism studies using molecular networkingBrendan Le Daré, Pierre-Jean Ferron, Aurélien Couette, et al.
Scientific Reports|November 17, 2020
New insights into quetiapine metabolism using molecular networkingBrendan Le Daré, Pierre-Jean Ferron, Pierre-Marie Allard, et al.
Pageof 3